
Category
Anticancer
Form
Injection
Strength
200mg/15ml, 500mg/30ml, 1000mg/50ml
CAS
50-18-0
Cyclophosphamide for Injection – Advanced Anticancer Chemotherapy Solution
Cyclophosphamide for Injection is a globally established anticancer chemotherapy formulation designed to deliver effective tumor control across a wide range of malignancies. Available in multiple strengths including 200 mg/15 ml, 500 mg/30 ml, and 1000 mg/50 ml, it is widely used in oncology protocols due to its strong cytotoxic activity. As an alkylating agent, Cyclophosphamide interferes with DNA replication in cancer cells, preventing tumor growth and spread. This formulation is highly versatile and commonly used in combination chemotherapy regimens for enhanced therapeutic outcomes. Manufactured under strict GMP-compliant conditions, it ensures consistent quality, safety, and global regulatory acceptance for hospitals and distributors.
Cyclophosphamide for Injection is a chemotherapy drug belonging to the alkylating agents class. It targets rapidly dividing cancer cells by disrupting DNA replication mechanisms. Commonly used in the treatment of lymphoma, leukemia, breast cancer, and various solid tumors. Widely used in combination chemotherapy regimens for enhanced efficacy. Also used in certain autoimmune conditions, demonstrating clinical versatility. Administered intravenously under professional medical supervision. Regular monitoring of blood counts, liver, and kidney function is essential during therapy.
Request QuoteImportant Information
- Cyclophosphamide for Injection is a chemotherapy drug belonging to the alkylating agents class.
- It targets rapidly dividing cancer cells by disrupting DNA replication mechanisms.
- Commonly used in the treatment of lymphoma, leukemia, breast cancer, and various solid tumors.
- Widely used in combination chemotherapy regimens for enhanced efficacy.
- Also used in certain autoimmune conditions, demonstrating clinical versatility.
- Administered intravenously under professional medical supervision.
- Regular monitoring of blood counts, liver, and kidney function is essential during therapy.
Storage
- Store Cyclophosphamide for Injection at 15°C to 25°C
- Protect from light and moisture
- Do not freeze the product
- Keep in original packaging until use
- Ensure proper storage conditions to maintain potency and stability
Shelf Life
- Shelf life typically ranges from 24 to 36 months
- Always verify expiry date before use
- Do not use expired medication
- Dispose of unused product according to pharmaceutical waste guidelines
Dosage
General
- Dosage is determined based on body surface area (mg/m²)
- Depends on type of cancer and patient condition
- Administered in cycles as per oncology protocols
Administration
- Given via intravenous infusion under medical supervision
- Ensure adequate hydration during treatment
- Monitor patient response continuously
Important
- Dose adjustments may be required based on tolerance
- Strictly administered in clinical settings
- Self-administration is not recommended
Manufacturing
- Manufactured in GMP-certified facilities
- Uses pharmaceutical-grade raw materials
- Produced in sterile injectable environments
- Advanced filtration and aseptic filling processes used
- Each batch undergoes rigorous quality control testing
- Ensures sterility, potency, and safety compliance
Precautions
- Use cautiously in patients with liver or kidney impairment
- Regular blood monitoring required due to bone marrow suppression risk
- Ensure adequate hydration to prevent bladder toxicity
- Avoid use during pregnancy unless medically necessary
- Administered only by oncology professionals
Side Effects
- Nausea and vomiting
- Hair loss (alopecia)
- Decreased white blood cell count
- Fatigue and weakness
- Bladder irritation (hemorrhagic cystitis)
- Loss of appetite
- Increased risk of infections
Expert View
- Cyclophosphamide for Injection remains a cornerstone chemotherapy drug globally due to its proven effectiveness.
- It is included in essential medicine lists across multiple countries.
- Its cost-effectiveness makes it accessible for large-scale oncology treatments.
- Highly compatible with combination therapies, improving clinical outcomes.
- A reliable and widely accepted option for oncologists worldwide.
Indications
- Treatment of lymphoma and leukemia
- Used in breast cancer therapy
- Effective for various solid tumors
- Used in autoimmune disorders such as lupus
- Applicable in combination chemotherapy regimens
Maintenance
- Follow complete chemotherapy cycle as prescribed
- Regular monitoring of blood parameters is required
- Maintain hydration during treatment
- Do not skip scheduled doses or cycles
- Follow oncologist guidance strictly for best outcomes
Frequently Asked Questions
Common product and supply questions.
What is the cost of cyclophosphamide 250 mg injection?+-
The cost of Cyclophosphamide for Injection varies based on dosage strength, manufacturer, and region. It is generally considered a cost-effective chemotherapy drug widely used in global oncology treatments and hospital supply chains.
How to give an injection of cyclophosphamide?+-
Cyclophosphamide for Injection is administered intravenously by trained healthcare professionals. Proper dosage calculation, hydration, and monitoring are essential to ensure safe and effective chemotherapy treatment in a clinical environment.
How long is a cyclophosphamide injection?+-
Cyclophosphamide for Injection is typically administered as an intravenous infusion over a specific duration depending on dosage and treatment protocol. The infusion time may range from minutes to hours under medical supervision.
Is cyclophosphamide a strong chemo drug?+-
Yes, Cyclophosphamide for Injection is a strong chemotherapy drug with potent anticancer activity. It is widely used in aggressive cancer treatments and combination therapy protocols to effectively control tumor growth.
Which is the most serious side effect of cyclophosphamide?+-
The most serious side effect of Cyclophosphamide for Injection is hemorrhagic cystitis, which affects the bladder. Adequate hydration and monitoring significantly reduce this risk during chemotherapy treatment.
